Skip to main content
OpenTrials

Clinical trial condition

Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia

Explore clinical trials studying Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia trial results

Recruiting

TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts

NCT03816319

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • VCU Massey Comprehensive Cancer Center Richmond, Virginia, United States
View Trial Details
Recruiting

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

NCT06484062

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • UC Comprehensive Cancer Center at Silver Cross New Lenox, Illinois, United States
View all 22 locations
View Trial Details

Related conditions